Tackling tumour scar tissue could be key to treating pancreatic cancer

by Queen Mary, University of LondonAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainThe first study in the world to take a detailed look

Updated on: April 09,2024

Tackling tumour scar tissue could be key to treating pancreatic cancer

by Queen Mary, University of LondonAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainThe first study in the world to take a detailed look

Updated on:April 09,2024

Researchers find less risky way to monitor breast cancer progression

by CU Anschutz Medical CampusSchematic for identifying subset of binding sites with TF footprints. (A) When TFs or nucleosomes are bound at TFBSs, they protect different lengths of DNA from nucle

Updated on: February 20,2024

Researchers find less risky way to monitor breast cancer progression

by CU Anschutz Medical CampusSchematic for identifying subset of binding sites with TF footprints. (A) When TFs or nucleosomes are bound at TFBSs, they protect different lengths of DNA from nucle

Updated on:February 20,2024

New computer platform helps match patients with cancer to trials of targeted therapy

byDana-Farber Cancer InstituteMatchMiner overview of data flow and modes of use. a) Data inputs from patients and trials are utilized by the MatchEngine to match patients to trials. b) Shown are

Updated on: January 12,2024

New computer platform helps match patients with cancer to trials of targeted therapy

byDana-Farber Cancer InstituteMatchMiner overview of data flow and modes of use. a) Data inputs from patients and trials are utilized by the MatchEngine to match patients to trials. b) Shown are

Updated on:January 12,2024

Immunotherapy in first-line standard therapy significantly improves survival in metastatic or recurrent cervical cancer

byVall d'Hebron Institute of OncologyCredit: CC0 Public DomainPublished inThe Lancet, results of the randomized phase III BEATcc academic trial (ENGOT-Cx10/GEICO 68-C/JGOG1084/GOG-3030

Updated on: January 26,2024

Immunotherapy in first-line standard therapy significantly improves survival in metastatic or recurrent cervical cancer

byVall d'Hebron Institute of OncologyCredit: CC0 Public DomainPublished inThe Lancet, results of the randomized phase III BEATcc academic trial (ENGOT-Cx10/GEICO 68-C/JGOG1084/GOG-3030

Updated on:January 26,2024

Research perspective: Cancer prevention with rapamycin

by Impact Journals LLCRapamycin prevents cancer by slowing tumor progression (hypothetical schema). (A) Rapamycin slows tumor progression and delays cancer and death from cancer. (B) Rapamycin slows t

Updated on: January 30,2024

Research perspective: Cancer prevention with rapamycin

by Impact Journals LLCRapamycin prevents cancer by slowing tumor progression (hypothetical schema). (A) Rapamycin slows tumor progression and delays cancer and death from cancer. (B) Rapamycin slows t

Updated on:January 30,2024

Overall cancer mortality continues to decline

by National Cancer InstituteCredit: CC0 Public DomainThe latest Annual Report to the Nation on the Status of Cancer finds that, for all cancer sites combined, cancer death rates continued to decl

Updated on: April 01,2024

Overall cancer mortality continues to decline

by National Cancer InstituteCredit: CC0 Public DomainThe latest Annual Report to the Nation on the Status of Cancer finds that, for all cancer sites combined, cancer death rates continued to decl

Updated on:April 01,2024

Cancer risk found to be higher in asthma patients

by Lori SolomonPeople with asthma are more likely to develop cancer, particularly those not using inhaled steroids, according to a study published online March 31 inCancer Medicine.Yi Guo, Ph.D.

Updated on: January 11,2024

Cancer risk found to be higher in asthma patients

by Lori SolomonPeople with asthma are more likely to develop cancer, particularly those not using inhaled steroids, according to a study published online March 31 inCancer Medicine.Yi Guo, Ph.D.

Updated on:January 11,2024

New chemical weapon to combat cancer

by University of GenevaMultipolar melanoma cells stained for centrosomes (gamma-tubulin in red, centrin in green) and DNA (DAPI in blue). Scale bar represents 5 µm. Credit: UNIGEUNIGE researchers

Updated on: March 01,2024

New chemical weapon to combat cancer

by University of GenevaMultipolar melanoma cells stained for centrosomes (gamma-tubulin in red, centrin in green) and DNA (DAPI in blue). Scale bar represents 5 µm. Credit: UNIGEUNIGE researchers

Updated on:March 01,2024

Team identifies key driver of cancer cell death pathway that activates immune cells

by University of Illinois at Urbana-ChampaignThe research team included, from left, research scientist Chengjian Mao, graduate student Xinyi Dai, biochemistry professor David Shapiro, graduate st

Updated on: February 23,2024

Team identifies key driver of cancer cell death pathway that activates immune cells

by University of Illinois at Urbana-ChampaignThe research team included, from left, research scientist Chengjian Mao, graduate student Xinyi Dai, biochemistry professor David Shapiro, graduate st

Updated on:February 23,2024

A new screening tool improves liver cancer detection

by Jordan Shaked,Yale UniversityTen-year risk of hepatocellular carcinoma (HCC). Credit:JAMA Network Open(2024). DOI: 10.1001/jamanetworkopen.2024.43608Hepatocellular carcinoma, a ty

Updated on: December 01,2024

A new screening tool improves liver cancer detection

by Jordan Shaked,Yale UniversityTen-year risk of hepatocellular carcinoma (HCC). Credit:JAMA Network Open(2024). DOI: 10.1001/jamanetworkopen.2024.43608Hepatocellular carcinoma, a ty

Updated on:December 01,2024

Fear of cancer recurrence common decades after surviving childhood cancer

by Lori SolomonA third of childhood cancer survivors experience fear of recurrence even decades later, according to a study published online Oct. 3 inJAMA Network Open.Alex Pizzo, from Concordia

Updated on: November 10,2024

Fear of cancer recurrence common decades after surviving childhood cancer

by Lori SolomonA third of childhood cancer survivors experience fear of recurrence even decades later, according to a study published online Oct. 3 inJAMA Network Open.Alex Pizzo, from Concordia

Updated on:November 10,2024

Novel biomarker for immune checkpoint inhibitors identified in human lethal cancers

by Liu Jia,Chinese Academy of SciencesA model depicting how the SETD2 inactivation sensitizes cancer cells to immune checkpoint blockade through the NR2F1-STAT1 pathway. Credit: Prof. Wang Yuexi

Updated on: January 26,2024

Novel biomarker for immune checkpoint inhibitors identified in human lethal cancers

by Liu Jia,Chinese Academy of SciencesA model depicting how the SETD2 inactivation sensitizes cancer cells to immune checkpoint blockade through the NR2F1-STAT1 pathway. Credit: Prof. Wang Yuexi

Updated on:January 26,2024